Desmopressin acetate for enuresis and diabetes insipidus

References

• Schulpen TW. The burden of nocturnal enuresis. Acta Paediatr.86(9), 981–984 (1997).
   PubMed Web of Science ®Google Scholar
• Hirasing RA, van Leerdam FJ, Bolk-Bennik L, Janknegt RA. Enuresis nocturna in adults. Scand. J. Urol. Nephrol.31, 533–536 (1997).
   PubMed Web of Science ®Google Scholar
• Dimson SB. Desmopressin as a treatment for enuresis. Lancet8024, 1260 (1977).
   Google Scholar
• Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Paediatr. Scand.67(6), 753–755 (1978).
   PubMed Web of Science ®Google Scholar
• Chiozza ML, Bernardinelli L, Caione P et al. An Italian epidemiological multicentre study of nocturnal enuresis. Br. J. Urol.81(Suppl. 3), 86–89 (1998).
   PubMedGoogle Scholar
• Rittig S, Schaumburg H, Schmidt F et al. Long-term home studies of water balance in patients with nocturnal enuresis. Scand. J. Urol. Nephrol. Suppl. 183, 25–26 (1997).
   Google Scholar
• Hunsballe JM, Hansen TK, Rittig S, Norgaard JP, Pedersen EB, Djurhuus JC. Polyuric and non-polyuric bedwetting – pathogenic differences in nocturnal enuresis. Scand. J. Urol. Nephrol. Suppl.173, 77–78 (1995).
   Google Scholar
• Hellstrom A-L, Hansson E, Hansson S et al. Micturition habits and continence in 7-year old Swedish school entrants. Eur. J. Pediatr.149, 434 (1990).
   PubMed Web of Science ®Google Scholar
• Miller K, Atkin B, Moody ML. Drug therapy for nocturnal enuresis. Current treatment recommendations. Drugs,44, 47 (1992).
   PubMedGoogle Scholar
• George CPL, Messerli FH, Genest J et al. Diurnal variation of plasma vasopressin in man. J. Clin. Endocrinol. Metab.41, 332–338 (1975).
   PubMed Web of Science ®Google Scholar
• Norgaard JP, Pedersen EB Djurhuus JC. Diurnal antidiuretic hormone levels in enuretics. J. Urol.134, 1029–1031 (1985).
   PubMed Web of Science ®Google Scholar
• Rittig S, Knudsen UB, Sorensen S. Long-term double-blind cross-over study of desmopressin intranasal spray in the management of nocturnal enuresis. In: Proceedings of an International Symposium: Desmopressin in Nocturnal Enuresis. Meadow SR (Ed.), London, Major Communications Limited, 43–49 (1989).
   Google Scholar
• Monda JM, Husmann DA. Primary nocturnal enuresis: a comparison among observation, imipramine, desmopressin acetate and bed-wetting alarm systems. J. Urol.154, 745 (1995).
   PubMed Web of Science ®Google Scholar
• Sukhai RN, Mol J, Harris AS. Combined therapy of enuresis alarm and desmopressin the treatment of nocturnal enuresis. Eur. J. Pediatr.148, 465 (1989).
   PubMed Web of Science ®Google Scholar
• Miller K, Klauber GT. Desmopressin acetate in children with severe primary nocturnal enuresis. Clin. Therap.12, 357 (1990).
   PubMedGoogle Scholar
• Eller DA, Homsy YL, Austin PF et al. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis. Scand. J. Urol. Nephrol.183, 41 (1997).
   Google Scholar
• Hogg RJ. Genetic factors as predictors for desmopressin treatment success. Scand. J. Urol. Nephrol. Suppl.183, 37 (1997).
   Google Scholar
• Fukuda I, Hizuka N, Takano K. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment. Endocr. J. 50(4), 437–443 (2003).
   PubMedGoogle Scholar
• Hammer M, Vilhsrdt H. Peroral treatment of diabetes insipidus with a polipeptide hormone analog. J. Pharmacol. Exper. Ther.234, 754–760 (1985).
   PubMed Web of Science ®Google Scholar
• Moses AM, Scheinman SJ, Oppennheim A. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin. J. Clin. Endocrinol. Metab.59, 1044–1049 (1984).
   PubMed Web of Science ®Google Scholar
• Mizuno H, Fujimoto S, Sugiyama Y et al. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Hormone Res.59, 297–300 (2003).
   PubMedGoogle Scholar
• Luzius H, Jans DA, Grunbaun EG, Moritz A, Rascher W, Fahrenholz F. A low affinity vasopressin V2 receptor in inherited nephrogenic diabetes insipidus. J. Recept. Res.12, 351–368 (1992).
   PubMed Web of Science ®Google Scholar
• Hjalmas K, Bengtsson B. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin. Pediatr.19–24 (1993).
   PubMedGoogle Scholar
• Moffatt ME, Harlos S, Kirshen AJ, Burd L. Desmopressin acetate and nocturnal enuresis: how much do we know? Pediatrics92(3), 420–425 (1993).
   PubMed Web of Science ®Google Scholar
• Gimpel GA, Warzak WJ, Kuhn BR, Walburn JN. Clinical perspectives in primary nocturnal enuresis. Clin. Pediatr.37(1), 23–29 (1998).
   PubMedGoogle Scholar
• van Kerrebroeck PE. Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents. BJU Int.89(4), 420–425 (2002).
   PubMed Web of Science ®Google Scholar
• Miller K, Goldberg S, Atkin B. Nocturnal enuresis. Experience with long term use of intranasally administered desmopressin. J. Pediatr.114, 723–726 (1989).
   PubMedGoogle Scholar
• Riccabona M, Oswald J, Glauninger P. Long-term use and tapered dose reduction of intranasal desmopressin in the treatment of enuretic children. Br J. Urol.81(Suppl. 3), 24–25 (1998).
   PubMedGoogle Scholar
• Tullus K, Bergdtrom R, Fosdal I, Winnegard I, HJalmas K. Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Swedish Enuresis Trial Group. Acta Pediatr.88, 1274–1278 (1999).
   PubMed Web of Science ®Google Scholar
• Wagner W, Johnson S, Walker D, Earther R, Wittner JA. A controlled comparison of two treatment for nocturnal enuresis. J. Paediatr.101, 302–307 (1982).
   PubMed Web of Science ®Google Scholar
• Pugner K, Holmes J. Nocturnal enuresis: economic impacts and self-esteem preliminary research results. Scand. J. Urol. Nephrol. Suppl.183, 65–69 (1997).
   Google Scholar
• Bernstein SA, Williford SI. Intranasal desmopressin-associated hyponatriemia: a case report and literature review. J. Fam. Pract.44, 203–208 (1997).
   PubMed Web of Science ®Google Scholar
• Robson WL, Norgaard JP, Leung AK. Hyponatriemia in patients with nocturnal enuresis treated with DDAVP Eur. J. Pediatr.155, 959–962 (1996).
   PubMed Web of Science ®Google Scholar
• Rew DA, Rundle JS. Assessment of the safety of regular DDAVP therapy in primary nocturnal enuresis Br. J. Urol.63, 352–353 (1989).
   PubMedGoogle Scholar
• Knudsen UB, Rittig S, Norgaard JP, Lundemose JB, Pederson EB, Djurhuus JC. Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study. Urol. Res.19, 237–240 (1991).
   PubMedGoogle Scholar
• Valenti G, Laera A, Gouraud S et al. Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Am. J. Physiol. Renal Physiol.283(5), 895–903 (2002).
   Google Scholar
• Vande Walle JGJ, Bogaert GA, Mattsson S et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int.97, 603–609 (2006).
   Google Scholar
• Hjalmas K, Arnold T, Bower W et al. Nocturnal enuresis: an international evidence-based management strategy. J. Urol.171, 2545–2561 (2004).
   PubMed Web of Science ®Google Scholar
• Hodge-Gray E, Caldamone AA. Primary nocturnal enuresis: a review. J. Sch. Nurs.14, 38–42 (1998).
   PubMedGoogle Scholar
• Norgaard JP, Ritting S, Djurhuus JC. Nocturnal enuresis: an approach to treatment based on pathogenesis. J. Pediatr.114, 705–710 (1989).
   PubMed Web of Science ®Google Scholar
• Del Gado R, Del Gaizo D, Cennamo M et al. Desmopressin is a safe drug for treatment of enuresis. Scand. J. Urol. Nephrol.39, 308–312 (2005).
   PubMed Web of Science ®Google Scholar